Orilanolimab (Anti-FcRn (FCGRT & B2M))
Orilanolimab (Anti-FcRn (FCGRT & B2M)) is a humanized monoclonal antibody targeting FcRn. It disrupts the interaction of FcRn and IgG for the treatment autoimmune diseases. MW :144.28 KD.
| Trivial name | SYNT001 |
| Catalog Number | A3000 |
| CAS# | 2066544-85-0 |
| Size | 1mg*25 |
| Supplier Page | http://www.selleckchem.com/products/orilanolimab-anti-fcrn-fcgrt---b2m.html |